Carcinogenic properties of dicarboxydine (gamma,gamma'-3,3'-benzidine dioxydibutyric acid).
D000284:Administration, Oral; D000818:Animals; D001560:Benzidines / Q000008:administration & dosage / Q000009:adverse effects*; D002087:Butyrates / Q000008:administration & dosage / Q000009:adverse effects; D002273:Carcinogens; D005260:Female; D007279:Injections, Subcutaneous; D008113:Liver Neoplasms / Q000139:chemically induced; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced; D051381:Rats; D012513:Sarcoma, Experimental / Q000139:chemically induced; D014594:Uterine Neoplasms / Q000139:chemically induced
D001560:Benzidines; D002087:Butyrates; D002273:Carcinogens